Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$0.29 - $0.45 $23,947 - $37,159
82,576 Added 10.16%
895,415 $322,000
Q3 2023

Nov 13, 2023

BUY
$0.34 - $0.69 $13,951 - $28,313
41,034 Added 5.32%
812,839 $276,000
Q2 2023

Aug 11, 2023

SELL
$0.52 - $0.91 $25,646 - $44,882
-49,321 Reduced 6.01%
771,805 $409,000
Q1 2023

May 15, 2023

BUY
$0.7 - $1.41 $807 - $1,627
1,154 Added 0.14%
821,126 $615,000
Q4 2022

Feb 13, 2023

BUY
$0.97 - $45.0 $37,615 - $1.75 Million
38,779 Added 4.96%
819,972 $975,000
Q3 2022

Nov 14, 2022

BUY
$1.22 - $40.8 $321,167 - $10.7 Million
263,252 Added 50.83%
781,193 $1.02 Million
Q2 2022

Aug 12, 2022

SELL
$1.15 - $3.34 $456,409 - $1.33 Million
-396,878 Reduced 43.38%
517,941 $828,000
Q1 2022

May 13, 2022

SELL
$2.96 - $7.76 $11,174 - $29,294
-3,775 Reduced 0.41%
914,819 $2.82 Million
Q4 2021

Feb 11, 2022

BUY
$7.4 - $11.66 $230,857 - $363,757
31,197 Added 3.52%
918,594 $6.8 Million
Q3 2021

Nov 12, 2021

BUY
$9.18 - $14.15 $974,842 - $1.5 Million
106,192 Added 13.59%
887,397 $10.2 Million
Q2 2021

Aug 13, 2021

BUY
$8.07 - $12.52 $485,854 - $753,766
60,205 Added 8.35%
781,205 $9.78 Million
Q1 2021

May 12, 2021

BUY
$8.57 - $15.79 $638,302 - $1.18 Million
74,481 Added 11.52%
721,000 $7.46 Million
Q4 2020

Feb 12, 2021

BUY
$5.98 - $12.47 $282,865 - $589,855
47,302 Added 7.89%
646,519 $5.39 Million
Q3 2020

Nov 13, 2020

BUY
$4.65 - $8.73 $968,790 - $1.82 Million
208,342 Added 53.3%
599,217 $3.69 Million
Q2 2020

Aug 13, 2020

BUY
$4.66 - $8.7 $345,161 - $644,400
74,069 Added 23.38%
390,875 $3.26 Million
Q1 2020

May 14, 2020

BUY
$5.05 - $15.01 $169,432 - $503,600
33,551 Added 11.84%
316,806 $1.91 Million
Q4 2019

Feb 13, 2020

BUY
$6.32 - $19.66 $898,944 - $2.8 Million
142,238 Added 100.87%
283,255 $3.93 Million
Q3 2019

Nov 12, 2019

BUY
$8.03 - $14.82 $29,357 - $54,181
3,656 Added 2.66%
141,017 $1.18 Million
Q2 2019

Aug 14, 2019

BUY
$11.88 - $16.94 $1.63 Million - $2.33 Million
137,361 New
137,361 $1.82 Million

Others Institutions Holding DTIL

About PRECISION BIOSCIENCES INC


  • Ticker DTIL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 110,818,000
  • Market Cap $550M
  • Description
  • Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...
More about DTIL
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.